Alam Kamran 4
4 · Taysha Gene Therapies, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2024-02-02$1.51/sh−1,288$1,945→ 840,937 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary transaction by the Reporting Person.